创伤性脑损伤中脑氧分压、脑血流与颅内压测量与最佳脑灌注压的关系
该研究回顾性分析单中心22例创伤性脑损伤患者的逐秒高频数据,涵盖脑氧分压、脑血流和颅内压监测,回顾性计算最佳脑灌注压。结果显示脑氧分压在最佳脑灌注压附近达峰,脑血流在最佳脑灌注压附近稳定、低于时下降、超过时升高,颅内压随脑灌注压线性下降;但最佳脑灌注压达标比例与各指标均值仅弱相关。
要点
- 脑氧分压在最佳脑灌注压附近达峰,超过最佳脑灌注压后不再改善。
- 脑血流在最佳脑灌注压附近稳定,低于时下降,超过时升高。
- 最佳脑灌注压达标比例与逐分钟均值仅弱相关(r=0.27、0.11、0.47)。
核心结论
- 最佳脑灌注压在同步脑氧分压和脑血流测量中具有生理学意义,但达标与均值相关性不强,个体患者中达标不总伴随最佳脑氧分压或脑血流。
- 数据不支持靶向并达到最佳脑灌注压可免除同步脑氧分压和脑血流监测的前提。
- 数据提示靶向最佳脑灌注压可能是合适的初始治疗策略,但未提供其应作为最高优先级靶向的证据。
研究设计与样本
- 回顾性分析单中心接受颅内压监测并具备脑氧分压和/或脑血流测量的创伤性脑损伤患者的高频数据。
- 共纳入22例患者,分析245.7天逐秒测量数据,包括6,748,866次脑氧分压测量、3,296,405次脑血流测量和10,264,770次颅内压测量。
- 逐秒数据按分钟平均后分析;最佳脑灌注压在患者照护中未计算或靶向,为回顾性计算,同时计算观察脑灌注压与最佳脑灌注压之差。
主要发现
- 汇总数据中,脑氧分压测量在最佳脑灌注压附近达峰,超过最佳脑灌注压后未见改善。
- 脑血流测量在最佳脑灌注压附近保持稳定,低于最佳脑灌注压时下降,脑灌注压超过最佳脑灌注压时升高。
- 颅内压随脑灌注压线性下降,与最佳脑灌注压无特定关系。
- 反向分析中,最佳脑灌注压处脑灌注压值百分比虽在脑氧分压、颅内压和脑血流当代治疗阈值的有利侧显著更高,但与逐分钟生理测量均值相关性不强(颅内压r=0.27、脑氧分压r=0.11、脑血流r=0.47;p<0.0001)。
临床怎么用
- 作者认为,靶向最佳脑灌注压可能是合适的初始治疗策略,但未提供其应作为最高优先级靶向的证据。
- 作者指出,数据不支持靶向并达到最佳脑灌注压可免除同步脑氧分压和脑血流监测的前提。
- 作者建议,进一步研究应在专门靶向最佳脑灌注压的治疗范式中探索这些关系。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Different paradigms for neurocritical care of traumatic brain injury (TBI) have emerged in conjunction with advanced neuromonitoring technologies and derived metrics. The priority for optimizing these metrics is not currently clear. The goal of this study was to determine whether achieving cerebral perfusion pressure (CPPopt) also improves other metrics like brain oxygenation and brain blood flow. METHODS: The authors performed a retrospective analysis of high-frequency data from patients with TBI who were treated at a single center and who had partial pressure of brain oxygen (PbtO2) measurements and/or brain blood flow measurements, while also undergoing intracranial pressure (ICP) monitoring. CPPopt was not calculated or targeted during patient care, but was retrospectively computed, as was the difference between the observed CPP and CPPopt. RESULTS: A total of 22 patients with ICP, PbtO2, and/or brain blood flow monitoring were included in the analysis, and 245.7 days of measurements obtained every second were analyzed including 6,748,866 PbtO2 measurements, 3,296,405 blood flow measurements, and 10,264,770 ICP measurements. The data obtained every second were averaged by minute for analysis. In summative data, PbtO2 measurements peaked near CPPopt and were not improved above CPPopt. Blood flow measurements remained stable near CPPopt, decreased below it, and increased when CPP exceeded CPPopt. ICP decreased linearly with CPP without a specific relationship with CPPopt. In an inverse analysis, the percentage of CPP values at CPPopt, although significantly higher on the favorable side of contemporary treatment thresholds of PbtO2, ICP, and blood flow, was not found to be strongly correlated with the mean values of the physiological measurements obtained every minute (r = 0.27, r = 0.11, and r = 0.47 for ICP, PbtO2, and blood flow, respectively; p < 0.0001). CONCLUSIONS: Although CPPopt was not targeted in the patients in this study, CPPopt was a physiologically significant value based on concurrent measurements of PbtO2 and blood flow. In summative data, achievement of CPPopt was associated with optimized PbtO2 and blood flow. Conversely, the correlation between achievement of CPPopt and the mean measurement value was not strong, strengthening the significance of CPPopt. In individual patients, achieving CPPopt is not always associated with optimal PbtO2 or blood flow. Further research should explore these relationships in treatment paradigms that specifically target CPPopt. These data do not support the premise that targeting and achieving CPPopt obviates the need for concurrent PbtO2 and blood flow monitoring. Although these data suggest that targeting CPPopt may be an appropriate initial treatment strategy, they do not provide evidence that CPPopt should be targeted with highest priority.
引用
- Pelah AI, Czosnyka M, Menacho S, et al. Focal brain oxygen, blood flow, and intracranial pressure measurements in relation to optimal cerebral perfusion pressure. J Neurosurg. 2023. PMID: 37976508. doi:10.3171/2023.8.JNS231519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。